Global Pharmacovigilance for Antiretroviral Drugs: Overcoming Contrasting Priorities
نویسندگان
چکیده
1 Forum for Collaborative HIV Research and Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America, 2 WHO Collaborating Centre for International Drug Monitoring, Uppsala, Sweden, 3 School of Public Health, University of Washington, Seattle, Washington, United States of America, 4 Quality Assurance and Safety: Medicines, Department of Essential Medicines and Pharmaceutical Policies, World Health Organization, Geneva, Switzerland, 5 Office of the US Global AIDS Coordinator, US Department of State, Washington, D.C., United States of America, 6 WHO Collaborating Centre for International Drug Monitoring, Uppsala, Sweden, 7 Department of HIV/AIDS, World Health Organization, Geneva, Switzerland, 8 WHO Collaborating Centre for Advocacy and Training in Pharmacovigilance, University of Ghana Medical School, Accra, Ghana, 9 Ranbaxy Inc., Princeton, New Jersey, United States of America, 10 Management S e s for Health, Strengthening Pharmaceutical Systems (SPS) Programs, Arlington, Virginia, United States of America, 11 Graduate Studies Program in Epidemiology, Federal University of Rio Grande do Sul, Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil, and Brazilian National Institute of Science and Technology for Health Technology Assessment (IATS CNPq), Porto Alegre, Brazil, 12 New York University School of Medicine, New York, New York, United States of America, 13 Forum for Collaborative HIV Research, Washington, D.C., United States of America
منابع مشابه
The Global Fund and pharmacovigilance systems in resource-limited settings.
1 Raine JM. Drug safety: reporting systems for the general public. BMJ 2012; 345: e4916. 2 Bakare N, Edwards IR, Stergachis A, et al. Global pharmacovigilance for antiretroviral drugs: overcoming contrasting priorities. PLoS Med 2011; 8: e1001054. 3 Global Fund to fi ght AIDS, Tuberculosis and Malaria. Final report of the third board meeting. http://www.theglobalfund.org/en/ board/meetings/four...
متن کاملMatching safety to access: global actors and pharmacogovernance in Kenya- a case study
BACKGROUND The Kenyan government has sought to address inadequacies in its National Pharmaceutical Policy and the Pharmacy and Poisons Board's (PPB) medicines governance by engaging with global actors (e.g. the World Health Organization). Policy actors have influenced the way pharmacovigilance is defined, how challenges are understood and which norms are requisite to address drug safety issues....
متن کاملPharmacovigilance: healthcare professionals' role in benefits versus harm analysis of drugs use.
Monitoring the negative effect of drugs is a concept that all healthcare professionals would be aware of as part of their professional responsibility. However since 1968, it has evolved into a structured science called 'Pharmacovigilance'. This review aims to sensitize Caribbean healthcare professionals to the global pharmacovigilance network of the World Health Organization and how their activ...
متن کاملPharmacovigilance: A Worldwide Master Key for Drug Safety Monitoring
Pharmacovigilance is like a sunshade to describe the processes for monitoring and evaluating ADRs and it is a key component of effective drug regulation systems, clinical practice and public health programmes. The number of Adverse Drug Reactions (ADRs) reported resulted in an increase in the volume of data handled, and to understand the pharmacovigilance, a high level of expertise is required ...
متن کاملEvolution of the Food and Drug Administration Approach to Liver Safety Assessment for New Drugs: Current Status and Challenges
Biosimilars are biological medicines, the active substances of which are highly similar to those of biologics that have already been authorized. As for any other medicine, the applicant of the biosimilar marketing authorization must submit a risk-management plan (RMP)/pharmacovigilance plan. The pharmacovigilance plan should take into account risks identified during product development, the pot...
متن کامل